What question did this study set out to answer?

This research aims to compare the safety and effectiveness of low-molecular-weight heparin versus warfarin in preventing venous thromboembolism in cancer patients.

August 12, 2002Archives of Internal Medicine

Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

View Full Paper

Ask AI

Bookmark

Authors

GMGuy MeyerVascular Medicine ZMZora MarjanovicSorbonne Université JVJudith ValckeHôpital Européen Georges-Pompidou

Discussion

Member takes

Implication

Randomized trial compares bleeding rates and effectiveness of low-molecular-weight heparin and warfarin in cancer patients, suggesting a safer alternative.

Key Points

This research aims to compare the safety and effectiveness of low-molecular-weight heparin versus warfarin in preventing venous thromboembolism in cancer patients.
Comparison of bleeding rates and treatment outcomes between low-molecular-weight heparin and warfarin
Analysis conducted in a population of cancer patients with venous thromboembolism
Warfarin treatment was linked to a high bleeding rate in patients with cancer and venous thromboembolism.
Low-molecular-weight heparin showed effectiveness similar to that of oral anticoagulants, potentially indicating safer treatment options.

Cite This Study

Meyer et al. (2002) studied this question.

synapsesocial.com/papers/69dee73940ea065679559c1a https://doi.org/10.1001/archinte.162.15.1729

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial compares bleeding rates and effectiveness of low-molecular-weight heparin and warfarin in cancer patients, suggesting a safer alternative.

Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider